Rito Bergemann

Employment

• Parexel International Switzerland Vice President, WW Head HEOR
  2021 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (63)

• PND14 QUALITY ASSESSMENT OF META-ANALYSES ON INTERVENTIONS FOR BELL'S PALSY USING AMSTAR 2
  Value in Health 2020 DOI: 10.1016/j.jval.2020.04.907
  +Save
• HT3 SYSTEMATIC ASSESSMENT OF HTA DECISIONS FOR PERSONALIZED MEDICINES FOR AN ORPHAN DISEASE: ACUTE MYELOID LEUKEMIA (AML)
  Value in Health 2020 DOI: 10.1016/j.jval.2020.04.033
  +Save
• PRO48 THE EPIDEMIOLOGY OF HUNTINGTON'S DISEASE IN US, EU5 AND JAPAN: A SYSTEMATIC LITERATURE REVIEW
  Value in Health 2020 DOI: 10.1016/j.jval.2020.04.1273
  +Save
• PRO15 HEALTHCARE RESOURCE UTILISATION AND ECONOMIC BURDEN OF GLIOBLASTOMA IN THE UNITED STATES: A SYSTEMATIC REVIEW
  Value in Health 2020 DOI: 10.1016/j.jval.2020.04.1244
  +Save
• CE4 COMPARISON OF NETWORK META-ANALYSIS (NMA) USING THE BAYESIAN AND FREQUENTIST APPROACH: CONCRETE EXAMPLE ON THE BASIS OF A PUBLISHED NMA IN RELAPSING REMITTING MULTIPLE SCLEROSIS AND PLAQUE PSORIASIS
  Value in Health 2019 DOI: 10.1016/j.jval.2019.09.052
  +Save
• PCN251 THE INCIDENCE OF SOFT TISSUE SARCOMA OVER THE NEXT TWO DECADES (2018-2040)
  Value in Health 2019 DOI: 10.1016/j.jval.2019.09.446
  +Save
• PCN373 RECENT COST PER QALY TRENDS OF NON-HAEMATOLOGICAL CANCERS ASSESSMENT AT NICE
  Value in Health 2019 DOI: 10.1016/j.jval.2019.09.568
  +Save
• PCN50 INDIRECT COMPARISON OF PARP INHIBITORS IN OVARIAN CANCER: NETWORK META-ANALYSIS
  Value in Health 2019 DOI: 10.1016/j.jval.2019.09.247
  +Save
• Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
  Pulmonary Circulation 2019 DOI: 10.1177/2045894019890549
  +Save
• PBI23 ANALYSIS OF REIMBURSEMENT STATUS OF 8 APPROVED CELL AND GENE THERAPIES IN THE USA, 6 MAJOR EUROPEAN COUNTRIES, AUSTRALIA, AND JAPAN
  Value in Health 2019 DOI: 10.1016/j.jval.2019.04.106
  +Save